Phase Ib Study of Chiauranib in Patients With Ovarian Cancer
Clinical trial NCT03166891 · COMPLETED
Trial details
- NCT number
- NCT03166891
- Sponsor
- Chipscreen Biosciences, Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-15
- Primary completion
- 2019-03-20
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.